In a study with 251 HER2 positive breast cancer patients, 42 patients had a LVEF drop of > 10% unit to a value below 50%, and 40% of these patients did not regain full cardiac function after enalapril and carvedilol treatment [42]. Here, ERBB2 is linked to breast carcinoma.